Comprehensive Safety & Risk Management

With years of experience navigating the complex landscape of FDA REMS requirements, our team of safety and regulatory specialists understand the intricacies of the essential, and often misunderstood, REMS components. MMS has a proven track record of developing and implementing successful REMS programs for clinical trial sponsors of all sizes. Additionally, our deep understanding of FDA expectations ensures that your REMS program will meet regulatory standards the first time, while efficiently mitigating risks associated with your drug.

Recognizing that no two REMS programs are identical, MMS offers tailored solutions that address the unique safety risks of your specific drug. Our personalized approach ensures that every aspect of your REMS program—from the development of the REMS materials to the REMS Assessment Plan—is meticulously crafted to suit your specific needs. This customization not only enhances the effectiveness of the program but also streamlines the compliance process.

MMS provides comprehensive REMS support, from the initial development phase through ongoing implementation, management, and assessment. Our services include the pre-approval support for FDA meetings and negotiations as well as support for REMS modifications or revisions.  By partnering with us, you gain access to a full spectrum of services designed to ease Sponsor burden and ensure seamless program execution.

Our commitment to quality is unwavering. MMS has been ISO:9001 certified since inception and we employ rigorous monitoring and evaluation systems to ensure that all REMS components are functioning as intended and are in full compliance with FDA requirements. Our proactive approach helps prevent potential FDA observations and ensures that your drug’s safety profile is continuously managed and optimized.

1. Nearly 70% of our experts hold a Master’s or Doctorate level degrees.  We pride ourselves in our industry-leading low attrition rates.  So, we can provide you with tenured experts that offer greater continuity and understanding of the intricacies of your program.
2. Safety is what we do! Annually, MMS produces thousands of CSR narratives, hundreds of Risk Management Plans (RMPs) and Periodic Aggregate Safety Reports (PASRs)), and numerous other documents including, REMS Assessment Reports, Benefit-Risk Assessments, and post marketing requirement studies.
3. We embrace and build the right technology to maintain the highest levels of innovation, like PVantage, which allows drug safety teams to collect, review and report adverse drug reactions and other safety events during a clinical trial or post market surveillance.